Previous Close | 64.52 |
Open | 63.30 |
Bid | 62.20 |
Ask | 65.05 |
Strike | 900.00 |
Expire Date | 2025-01-17 |
Day's Range | 60.70 - 64.20 |
Contract Range | N/A |
Volume | |
Open Interest | 1.92k |
Eli Lilly (LLY) concluded the recent trading session at $887.16, signifying a +0.18% move from its prior day's close.
FDA approves Sanofi's Dupixent for COPD. Eli Lilly is set to invest $4.5 billion to build a new manufacturing and research site in Indiana.
The FDA confirmed Thursday that Eli Lilly has increased production of its blockbuster weight-loss drug Zepbound and type 2 diabetes drug Mounjaro, implying the company can now supply enough doses to meet current demand. What does that mean for the marketplace?